POTTER v. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.

District Court, D. New Jersey·Decided June 30, 2022·No. 3:15-cv-07658·Unknown

Opinion

NOT FOR PUBLICATION

UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY

IN RE VALEANT PHARMACEUTICALS Civil Action No. 15-7658 (MAS) (LHG) INTERNATIONAL, INC. SECURITIES LITIGATION MEMORANDUM OPINION

SHIPP, District Judge This matter comes before the Court on the Report and Recommendation (the “Report”) of the Honorable Dennis M. Cavanaugh, U.S.D.J. (ret.) (the “Special Master”), recommending awarding $75,000 in fees to Entwistle & Cappucci LLP (“Entwistle”). (ECF No. 895.) Objector Cathy Lochridge (“Lochridge”) objected to the Special Master’s Report (ECF No. 908), and Entwistle and Class Counsel separately opposed Lochridge’s objection (ECF No. 930, 931). Having considered the Special Master’s Report and reviewed the parties’ submissions, the Court decides this matter without oral argument under Local Civil Rule 78.1. For the reasons below, the Court adopts the Special Master’s Report and awards Entwistle $75,000 in fees and costs. 1. BACKGROUND This matter concerns whether the Court should award $75,000 in fees to Entwistle for its work on behalf of Timber Hill LLC (“Timber Hill”) in the class action. Notably, any fee award to Entwistle comes from a previously allocated award to Lead Counsel and not from the settlement class members. In support of its request for fees, Entwistle submitted the declaration of Andrew J. Entwistle (the “Entwistle Declaration”), which detailed the thousands of hours Entwistle devoted to this litigation. (See generally Entwistle Decl, ECF No. 985.) The Entwistle Declaration

specifies that a group of five attorneys at Entwistle spent over 2000 billable hours in service of Timber Hill, representing a lodestar of over $2.8 million. (Entwistle Decl. Ex. A (Time Report), ECF No. 985-1.) Those hours were not in vain, as Entwistle’s work ensured that derivatives investors (like Timber Hill) were included in the class action. (Entwistle Decl. ¥ 3.) The firm’s work further included litigating the issue of a cap on derivatives investors’ ultimate recovery—an issue ultimately rendered moot when Entwistle “received information that the cap would have no practical impact on the recovery of derivatives investors under the Settlement.” (/d.) Entwistle’s $75,000 request (less than three percent of its lodestar) spurred class action objector Cathy Lochridge into action. Although she stands to lose nothing from Entwistle’s request, Lochridge argues that Entwistle’s fees are unreasonable based on some undisclosed collusive agreement between Entwistle and Lead Counsel. (Objector’s Resp. to Entwistle’s Fees Mot. 1 (“Cass [sic] counsel have attempted to hide a secret deal to buy Timber Hill’s appeals in the Third Circuit.”), ECF No. 883.) Unsurprisingly, the Special Master found no support for this lawyer-driven collusion and ruled that Entwistle’s request was reasonable. (R. & R. 3 (“The Special Master finds that Entwistle & Cappucci LLP devoted substantial time and resources to this litigation and that counsel’s advocacy in this case has been substantial and of high quality.”), ECF No. 895.) .

Lochridge renewed her objection to the Special Master’s Report, again arguing that the secret deal precluded an award of fees. The heart of Lochridge’s argument is that Class Counsel agreed not to oppose Entwistle’s fee award in exchange for Entwistle dropping an appeal before the Third Circuit. (See Objector’s Br. to R. & R. 1-3, ECF No. 908.) As evidence, Lochridge points to another objection she filed in the Third Circuit requesting that Class Counsel and Entwistle “clarify whether there has been payment or promise of payment or other consideration in

connection with the requested dismissal.” (Lochridge’s Resp., 774A v. Valeant Pharms. Int'l, Inc., No. 21-1218 (3d Cir. Oct. 19, 2021), ECF No. 56.) Curiously, Lochridge does not explain how a concern over collusion between Class Counsel and Entwistle morphed into proof of collusion between the pair.' In any event, both Timber Hill and Class Counsel opposed Lochridge’s objection. (ECF Nos. 930, 931.) II. STANDARD OF REVIEW The Court reviews reports and recommendations from the Special Master’s findings of fact and conclusions of law de novo. Fed. R. Civ. P. 53(f)(3)-(4); (Am. Order Appointing Special Master 9 11, ECF No. 871.). The Court “may adopt or affirm, modify, wholly or partly reject or reverse, or resubmit to the master with instructions.” Fed. R. Civ. P. 53(f)(1); (Am. Order Appointing Special Master J 10.) Il. LEGAL STANDARD Under Federal Rule of Civil Procedure 23, the Court must approve an award of fees and costs in a class action settlement. Fed. R. Civ. P. 23(h). “[A] thorough judicial review of fee applications is required in all class action settlements.” Jn re Prudential Ins. Co. Am. Sales Practice Litig., 148 F.3d 283, 333 (3d Cir. 1998) (alteration in original) (quoting re Gen. Motors Corp. Pick-Up Truck Fuel Tank Prods. Liab. Litig., 55 F.3d 768, 819 (3d Cir. 1995)). Even under this

' She attempts to do so by pointing to a cherrypicked statement by Class Counsel in the Third Circuit appeal that “Timber Hill intends to seek approval from the district court for, and lead counsel for Plaintiffs-Appellees has agreed that it will not oppose, a modest fee award.” (Class Counsel’s Reply to Lochridge’s Resp. 2, TIAA, No. 21-1218, ECF No. 58.) She ignores the next two sentences: “However, no payment or consideration has been made, nor shall any be made, absent district court approval pursuant to Rule 23(e)(5)(B). Timber Hill’s forthcoming request for district court approval does not impact this Court’s authority to dismiss the appeal.” (/d. at 2-3.) ? Lochridge also filed a motion for sur-reply. (ECF No. 894.) The Court has considered Lochridge’s sur-reply in its decision today; the sur-reply does not change the Court’s conclusion that Entwistle’s fees are reasonable.

Free access — add to your briefcase to read the full text and ask questions with AI

POTTER v. VALEANT PHARMACEUTICALS INTERNATIONAL, INC., (D.N.J. 2022).

POTTER v. VALEANT PHARMACEUTICALS INTERNATIONAL, INC. (POTTER v. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

In Re Diet Drugs
582 F.3d 524 (Third Circuit, 2009)
In Re Safety Components, Inc. Securities Litigation
166 F. Supp. 2d 72 (D. New Jersey, 2001)
In Re AT & T Corp.
455 F.3d 160 (Third Circuit, 2006)
Sullivan v. DB Investments, Inc.
667 F.3d 273 (Third Circuit, 2011)